Krystal Biotech (KRYS) Inventory Average (2023 - 2026)

Krystal Biotech's Inventory Average history runs 4 years deep, the most recent figure standing at $41.6 million for Q1 2026.

• In Q1 2026, Inventory Average rose 47.25% year-over-year to $41.6 million; the TTM figure through Mar 2026 stood at $41.6 million (up 47.25% YoY), while the FY2025 annual figure was $33.5 million, up 99.99% from the prior year.
• Inventory Average came in at $41.6 million for Q1 2026 at Krystal Biotech, up from $39.1 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $41.6 million in Q1 2026 to a low of $6.1 million in Q4 2023.
• A 4-year average of $23.8 million and a median of $25.4 million in 2024 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average surged 267.68% in 2024 and jumped 47.25% in 2026, its largest moves.
• Krystal Biotech's Inventory Average stood at $6.1 million in 2023, then soared by 267.68% to $22.5 million in 2024, then jumped by 73.23% to $39.1 million in 2025, then grew by 6.42% to $41.6 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $41.6 million, $39.1 million, and $34.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison